BORDERLINE RESECTABLE PANCREATIC CANCER: Need for Standardization and Methods for Optimal Clinical Trial Design

Methodological limitations of prior studies have prevented progress in the treatment of patients with borderline resectable pancreatic adenocarcinoma. Shortcomings have included the absence of staging and treatment standards and pre-existing biases with regard to the use of neoadjuvant therapy and t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ann Surg Oncol
Main Authors: Katz, Matthew HG, Marsh, Robert, Herman, Joseph M., Shi, Qian, Collison, Eric, Venook, Alan, Kindler, Hedy, Alberts, Steven, Philip, Philip, Lowy, Andrew M., Pisters, Peter, Posner, Mitchell, Berlin, Jordan, Ahmad, Syed A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600517/
https://ncbi.nlm.nih.gov/pubmed/23435609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-013-2886-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados